Growth Metrics

AtriCure (ATRC) Cash from Investing Activities (2016 - 2025)

AtriCure (ATRC) has disclosed Cash from Investing Activities for 16 consecutive years, with -$2.6 million as the latest value for Q4 2025.

  • Quarterly Cash from Investing Activities rose 82.29% to -$2.6 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$14.6 million through Dec 2025, down 148.12% year-over-year, with the annual reading at -$14.6 million for FY2025, 148.12% down from the prior year.
  • Cash from Investing Activities for Q4 2025 was -$2.6 million at AtriCure, roughly flat from -$2.6 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $63.6 million in Q1 2021, with the low at -$25.1 million in Q3 2021.
  • Average Cash from Investing Activities over 5 years is $5.3 million, with a median of -$302000.0 recorded in 2021.
  • The sharpest move saw Cash from Investing Activities skyrocketed 550.14% in 2022, then tumbled 427.39% in 2024.
  • Over 5 years, Cash from Investing Activities stood at $1.1 million in 2021, then surged by 550.14% to $7.0 million in 2022, then crashed by 139.79% to -$2.8 million in 2023, then crashed by 427.39% to -$14.7 million in 2024, then surged by 82.29% to -$2.6 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at -$2.6 million, -$2.6 million, and -$7.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.